Pierre-Yves Aubert

Angel investor in Lille

Invests in AI

Pierre-Yves Aubert's investor profile lists AI alongside Healthcare & Biotech, Biotech & Pharma and SaaS & Enterprise, at early-stage venture. The record holds 1 deal, among them Beamy.

Email Investor

Email Investor

Credits to line up before an early-stage round

Pierre-Yves Aubert backs companies at early-stage venture. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Beamy

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, Biotech & Pharma, SaaS & Enterprise, Consumer & Retail, Developer Tools & Data and 2 more
Rounds
Early-stage venture
Profile
Angel investor
Deals on record
1
Based in
Lille, France

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Pierre-Yves Aubert invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Pierre-Yves Aubert's investor profile, together with Healthcare & Biotech, Biotech & Pharma and SaaS & Enterprise. The stages on record are early-stage venture.
Which companies has Pierre-Yves Aubert backed?
The record lists 1 deal, including Beamy. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Pierre-Yves Aubert?
For a company raising an early-stage round, AI Perks lists credits such as Azure OpenAI (up to $150,000), Redis (up to $10,000), Appwrite (up to $20,000) and DigitalOcean (up to $100,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor